142 related articles for article (PubMed ID: 16723466)
1. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma.
Henry E; Newby DE; Webb DJ; Hadoke PW; O'Brien CJ
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2528-32. PubMed ID: 16723466
[TBL] [Abstract][Full Text] [Related]
2. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
[TBL] [Abstract][Full Text] [Related]
3. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.
Helmy A; Newby DE; Jalan R; Hayes PC; Webb DJ
Gut; 2003 Mar; 52(3):410-5. PubMed ID: 12584225
[TBL] [Abstract][Full Text] [Related]
4. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
[TBL] [Abstract][Full Text] [Related]
5. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
6. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
7. Peripheral endothelial dysfunction in normal pressure glaucoma.
Henry E; Newby DE; Webb DJ; O'Brien C
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1710-4. PubMed ID: 10393040
[TBL] [Abstract][Full Text] [Related]
8. Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis.
Böhm F; Ahlborg G; Pernow J
Clin Sci (Lond); 2002 Mar; 102(3):321-7. PubMed ID: 11869173
[TBL] [Abstract][Full Text] [Related]
9. Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.
Shemyakin A; Böhm F; Wagner H; Efendic S; Båvenholm P; Pernow J
J Cardiovasc Pharmacol; 2006 Mar; 47(3):385-90. PubMed ID: 16633080
[TBL] [Abstract][Full Text] [Related]
10. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
[TBL] [Abstract][Full Text] [Related]
11. Combined endothelin receptor blockade evokes enhanced vasodilatation in patients with atherosclerosis.
Böhm F; Ahlborg G; Johansson BL; Hansson LO; Pernow J
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):674-9. PubMed ID: 11950709
[TBL] [Abstract][Full Text] [Related]
12. Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors.
Bellien J; Iacob M; Monteil C; Rémy-Jouet I; Roche C; Duflot T; Vendeville C; Gutierrez L; Thuillez C; Richard V; Joannidès R
J Hypertens; 2017 Jun; 35(6):1204-1212. PubMed ID: 28441692
[TBL] [Abstract][Full Text] [Related]
13. Endothelin receptor blockade improves endothelial function in atherosclerotic patients on angiotensin converting enzyme inhibition.
Böhm F; Beltran E; Pernow J
J Intern Med; 2005 Mar; 257(3):263-71. PubMed ID: 15715683
[TBL] [Abstract][Full Text] [Related]
14. Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation.
Vaughan RB; Angus PW; Chin-Dusting JP
Gut; 2003 Oct; 52(10):1505-10. PubMed ID: 12970146
[TBL] [Abstract][Full Text] [Related]
15. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
Ferro CJ; Haynes WG; Hand MF; Webb DJ
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
[TBL] [Abstract][Full Text] [Related]
16. Cold pressor test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma.
Holló G; Lakatos P; Farkas K
J Glaucoma; 1998 Apr; 7(2):105-10. PubMed ID: 9559496
[TBL] [Abstract][Full Text] [Related]
17. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
Hand MF; Haynes WG; Webb DJ
Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085
[TBL] [Abstract][Full Text] [Related]
18. Contribution of endothelin 1 to the vascular effects of diesel exhaust inhalation in humans.
Langrish JP; Lundbäck M; Mills NL; Johnston NR; Webb DJ; Sandström T; Blomberg A; Newby DE
Hypertension; 2009 Oct; 54(4):910-5. PubMed ID: 19687345
[TBL] [Abstract][Full Text] [Related]
19. Reduced endothelin-1- and nitric oxide-mediated arteriolar tone in hypertensive renal transplant recipients.
Passauer J; Lässig G; Büssemaker E; Pistrosch F; Gross P
Kidney Int; 2004 May; 65(5):1782-9. PubMed ID: 15086917
[TBL] [Abstract][Full Text] [Related]
20. Intracoronary endothelin receptor blockade improves endothelial function in patients with coronary artery disease.
Böhm F; Jensen J; Svane B; Settergren M; Pernow J
Can J Physiol Pharmacol; 2008 Nov; 86(11):745-51. PubMed ID: 19011669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
